Burden of Disease of Chronic Kidney Disease (CKD), Type 2 Diabetes Mellitus (T2DM), and Comorbid T2DM/CKD in Alberta, Canada: A Non-interventional Study Using Administrative Health Data
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 588,170
- 主要终点
- Incidence and prevalence
研究概览
简要总结
The purpose of the research study is to describe the burden of disease among three different cohorts of patients: (1) patients diagnosed with CKD, (2) those with T2DM; and (3) those with T2DM and comorbid CKD.
详细描述
Chronic kidney disease (CKD) has been ranked as the 10th leading cause of death in Canada as of 2013, while type 2 diabetes mellitus (T2DM) is one of the fastest growing diseases in Canada. There is a growing body of evidence that has examined these populations in real-world settings in Canada. The study described below will add to the growing body of literature that has examined CKD patients in Alberta and will contribute to an understanding of the epidemiology of CKD by stage, as well as healthcare resource utilization (HCRU) and costs. Furthermore, this study will contribute to a more nuanced understanding of the epidemiology, treatment patterns, HCRU and costs, and adverse events for T2DM patients with and without comorbid CKD in Alberta.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Age < 18 years
结局指标
主要结局
Incidence and prevalence
时间窗: 2010 to 2018 fiscal years
Incidence and prevalence of CKD (by stage), T2DM, and comorbid T2DM/CKD, including 1-, 4-, and 5-year period prevalence and incidence
次要结局
- Comorbidity and complication profiles and rates(2010 to 2019 fiscal years)
- Healthcare resource use (HCRU) and associated costs for CKD patients(2010 to 2019 fiscal years)
- Factors that influence the progression of CKD in patients(2010 to 2019 fiscal years)
- Stage-to-stage progression of CKD across the follow-up years in patients with CKD(2010 to 2019 fiscal years)
- Treatment patterns(2010 to 2019 fiscal years)
研究者
Tara Cowling
Director and Managing Principal
Medlior Health Outcomes Research Ltd